IRIDEX Corp
IRIXHealthcare·Medical Devices·USA·Nano·NASD·Nov 12 • 3:58 PM ET
0.71+0.06 (8.58%)
2026-11-13 13:23 CET
Market cap
$12.46M
Revenue, TTM
51.57 USD m
Net income, TTM
-3.55 USD m
Free cash flow, TTM
-2.00 USD m
EPS diluted, TTM
-0.21
Price
IRIX against its 20, 50 and 200-day averagesPatternshover a marker to name it
57.0% under the 52-week high of 1.65 on 22 Jan 2026. 52-week low 0.61 on 16 Sep 2026. Last 15 sessions, 19.1% high to low
Volume 0.00× normal · the session has not printed · the line is the 50-bar volume average
Setup. RS line 5
CANSLIM 2 of 6 — fails: EPS Growth Qtr Over Qtr: High (>25%); 52-Week High/Low: 0-10% below High; Performance: Year +50%; Institutional Ownership: Over 50%
VCP 3 of 6 — fails: 200-Day Simple Moving Average: Price above SMA200; 50-Day Simple Moving Average: SMA50 above SMA200; 52-Week High/Low: 0-10% below High
Minervini 0 of 4 — fails: 200-Day Simple Moving Average: Price above SMA200; 50-Day Simple Moving Average: SMA50 above SMA200; 52-Week High/Low: 0-10% below High; Performance: Year +50%
Zanger 0 of 5 — fails: RSI (14): Not Oversold (>50); Performance: Week +10%; 20-Day High/Low: 0-5% below High; Relative Volume: Over 1.5; 200-Day Simple Moving Average: Price above SMA200
Leaders 0 of 5 — fails: 50-Day Simple Moving Average: Price above SMA50; 200-Day Simple Moving Average: Price above SMA200; Performance: Year +50%; Average Volume: Over 500K; 52-Week High/Low: 0-10% below High
Breakout 0 of 4 — fails: 52-Week High/Low: New High; Relative Volume: Over 2; 50-Day Simple Moving Average: Price above SMA50; 200-Day Simple Moving Average: Price above SMA200
Growth 2 of 4 — fails: EPS Growth Qtr Over Qtr: High (>25%); Return on Equity: Over +15%
Quality 1 of 5 — fails: Return on Equity: Over +15%; Net Profit Margin: High (>20%); Debt/Equity: Low (<0.1) — not on the tape: P/E: Under 25
Value 0 of 4 — fails: Return on Equity: Over +15%; Debt/Equity: Low (<0.1) — not on the tape: P/E: Under 15; P/B: Under 2
Income 0 of 4 — fails: Dividend Growth: Growing 2+ Years — not on the tape: Dividend Yield: Over 2%; Payout Ratio: Low (<20%); P/E: Under 25
Small Cap 1 of 4 — fails: Average Volume: Over 500K; 200-Day Simple Moving Average: Price above SMA200; Performance: Year +50%
Accumulation 0 of 4 — fails: Institutional Ownership: Over 30%; Institutional Transactions: Over +10%; 200-Day Simple Moving Average: Price above SMA200; Performance: Year Up
Relative Strength 0 of 3 — fails: Performance: Year +100%; 200-Day Simple Moving Average: Price above SMA200; Average Volume: Over 500K
Profile
IRIX52-week range, 10% of the way up
0.611.65
IRIDEX Corp. engages in developing, manufacturing, and marketing medical systems, delivery devices, and consumable instrumentation for the ophthalmology market. Its products include lasers, laser delivery and glaucoma devices, retinal surgical instruments, veterinary, and ENT. The company was founded by Eduardo Arias, Theodore A. Boutacoff, David M. Buzawa and James L. Donovan in February 1989 and is headquartered in Mountain View, CA.
| Employees | 93 |
|---|---|
| IPO | Feb 16, 1996 |
| Beta | 0.63 |
| ATR, 14d | 0.06 |
| Rel volume | 0.00 |
| Short float | 0.37% |
| Insider own | 38.84% |
| Inst own | 17.20% |
Snapshot
6 groupsValuation
| Index | - |
|---|---|
| Market Cap | $12.46M |
| Enterprise Value | 17.79M |
| Income | -3.55M |
| Sales | 51.57M |
| Book / share | -0.14 |
| Cash / share | 0.27 |
| Dividend Est. | - |
| Dividend TTM | - |
| Dividend Ex-Date | - |
| Dividend Gr. 3/5Y | - - |
| Payout | - |
| Employees | 93 |
| IPO | Feb 16, 1996 |
Ratios
| Price / earnings | - |
|---|---|
| Forward price / earnings | - |
| Price / earnings / growth | - |
| Price / sales | 0.24 |
| Price / book | - |
| Price / cash | 2.66 |
| Price / free cash flow | - |
| Value / cash profit | - |
| Value / sales | 0.34 |
| Quick Ratio | 1.08 |
| Current Ratio | 1.82 |
| Debt / equity | 1.10 |
| Long-term debt / equity | 1.06 |
| Options and short | Yes / Yes |
Earnings
| Earnings / share | -0.21 |
|---|---|
| Earnings next year | 0.00 |
| Earnings next quarter | -0.04 |
| Earnings this year | 53.85% |
| Earnings next year | 100.00% |
| Earnings growth, 5 years | - |
| Past earnings growth | 17.90% 10.54% |
| Past sales growth | -2.58% 7.70% |
| Earnings vs last year | 36.91% |
| Sales vs last year | 3.68% |
| Earnings vs last quarter | -22.80% |
| Sales vs last quarter | -7.41% |
| Earnings | Nov 17 AMC |
| Surprise | -600.00% -7.51% |
Ownership
| Insiders own | 38.84% |
|---|---|
| Insider trades | 21.86% |
| Institutions own | 17.20% |
| Institution trades | -0.92% |
| Return on assets | -12.06% |
| Return on equity | -73.15% |
| Return on capital | -47.22% |
| Gross Margin | 35.31% |
| Operating margin | -5.39% |
| Profit Margin | -6.88% |
| 20-day average | -2.35% |
| 50-day average | -0.41% |
| 200-day average | -29.31% |
Technical
| Shares out | 17.45M |
|---|---|
| Shares floating | 10.74M |
| Short / float | 0.37% |
| Short ratio | 0.10 |
| Short interest | 0.04M |
| 52-week high | 1.65 -57.0% |
| 52-week low | 0.61 +16.8% |
| Volatility | 7.59% 7.60% |
| Average range | 0.06 |
| Strength index | 48.12 |
| Market sensitivity | 0.63 |
| Relative volume | 0.00 |
| Avg Volume | 384.09K |
| Volume | 0 |
Performance
| Perf Week | 4.33% |
|---|---|
| Perf Month | -13.91% |
| Perf Quarter | -17.12% |
| Perf Half Y | -29.76% |
| Perf YTD | -37.77% |
| Perf Year | -25.64% |
| Perf 3Y | -65.89% |
| Perf 5Y | -91.18% |
| Perf 10Y | -95.60% |
| Recommendation | 1.00 |
| Target Price | 2.75 |
| Prev Close | 0.71 |
| Price | 0.71 |
| Change % | 0.00% |
Analyst ratings
latest 4 of 4| Date | Action | Analyst | Rating change | Target | Implied |
|---|---|---|---|---|---|
| Nov 03, 2017 | Resumed | ROTH Capital | Buy | ||
| Dec 21, 2016 | Initiated | ROTH Capital | Buy | ||
| Jan 26, 2016 | Initiated | Singular Research | Buy | $11.50 | +1,521.0% |
| Jan 03, 2007 | Initiated | First Albany | Buy | $15.50 | +2,084.8% |
Peers
Mkt capInsider trading
latest 14 of 69| Insider | Relationship | Date | Transaction | Cost | Shares | Value | Total held | Form |
|---|---|---|---|---|---|---|---|---|
| Lin Shih-Yao David | 10% Owner | Feb 05 '26 | Buy | 1.45 | 40,535 | 58,755 | 1,098,858 | Oct 07 06:10 AM |
| Lin Shih-Yao David | 10% Owner | Jan 27 '26 | Buy | 1.48 | 33,013 | 49,014 | 1,034,312 | Oct 07 06:10 AM |
| Lin Shih-Yao David | 10% Owner | Jan 23 '26 | Buy | 1.48 | 30,000 | 44,394 | 1,001,299 | Oct 07 06:10 AM |
| Lin Shih-Yao David | 10% Owner | Mar 17 '26 | Buy | 1.31 | 22,805 | 29,872 | 1,157,363 | Oct 07 06:10 AM |
| Lin Shih-Yao David | 10% Owner | Feb 04 '26 | Buy | 1.41 | 19,324 | 27,247 | 1,058,323 | Oct 07 06:10 AM |
| Lin Shih-Yao David | 10% Owner | Jan 08 '26 | Buy | 1.20 | 20,000 | 24,000 | 971,299 | Oct 07 06:10 AM |
| Lin Shih-Yao David | 10% Owner | Mar 23 '26 | Buy | 1.33 | 17,526 | 23,310 | 1,174,889 | Oct 07 06:10 AM |
| Lin Shih-Yao David | 10% Owner | Feb 11 '26 | Buy | 1.43 | 15,703 | 22,455 | 1,114,690 | Oct 07 06:10 AM |
| Lin Shih-Yao David | 10% Owner | Feb 23 '26 | Buy | 1.41 | 14,943 | 21,070 | 1,129,733 | Oct 07 06:10 AM |
| Lin Shih-Yao David | 10% Owner | Dec 12 '25 | Buy | 0.97 | 20,000 | 19,400 | 905,648 | Oct 07 06:10 AM |
| Lin Shih-Yao David | 10% Owner | Dec 09 '25 | Buy | 0.94 | 20,000 | 18,800 | 866,756 | Oct 07 06:10 AM |
| Lin Shih-Yao David | 10% Owner | Dec 10 '25 | Buy | 0.94 | 18,892 | 17,664 | 885,648 | Oct 07 06:10 AM |
| Lin Shih-Yao David | 10% Owner | Dec 19 '25 | Buy | 0.97 | 14,202 | 13,776 | 938,929 | Oct 07 06:10 AM |
| Lin Shih-Yao David | 10% Owner | Dec 15 '25 | Buy | 0.94 | 11,404 | 10,720 | 917,052 | Oct 07 06:10 AM |
Held by
AUMNews
latest 14 of 198- Iridex Must Prove Its Back-Half Rebound Is Real As Retina Weakness Tests Guidance (Earnings Whispers) -6.73%
- Iridex to Report Third Quarter 2026 Financial Results on November 17, 2026 (GlobeNewswire)
- Iridex Announces the Publication of Two-Year Independent Study Supporting Benefits of MicroPulse Technology for Early to Advanced Glaucoma (GlobeNewswire)
- Iridex Completes Relocation of Manufacturing Facility to San Jose, California (GlobeNewswire) +7.28%
- IRIDEX Corp (IRIX) (Q2 2026) Earnings Call Highlights: Cyclo-G6 Surges 35% as Company Achieves ... (GuruFocus.com) -15.83%
- Iridex: Q2 Earnings Snapshot (Associated Press) +5.69%
- Iridex Reports Second Quarter 2026 Financial Results (GlobeNewswire)
- Iridex to Report Second Quarter 2026 Financial Results on August 18, 2026 (GlobeNewswire)
- Iridex Adds EndoProbe Handpieces to EyeProGPO Product Offering (GlobeNewswire)
- Iridex to Present at the Planet MicroCap Las Vegas 2026 Conference (GlobeNewswire)
- IRIDEX Corp (IRIX) Q1 2026 Earnings Call Highlights: Navigating Challenges with Strategic ... (GuruFocus.com)
- Iridex: Q1 Earnings Snapshot (Associated Press)
- Iridex Reports First Quarter 2026 Financial Results (GlobeNewswire)
- Iridex to Report First Quarter 2026 Financial Results on May 19, 2026 (GlobeNewswire)
Quarterly earnings
2026Q2 EPS -0.070 missed -0.010, from -0.060 a year earlier. Sales 12.57 missed 13.59, from 13.57 a year earlier
The outline behind the bar is the estimate. The filled bar is the print. Green beat it, red missed it.
| Period | Reported | EPS adjusted | EPS est | EPS reported | Sales act, USD m | Sales est, USD m | Surprise | Year-ago quarter | Analysts | Next session |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026Q3ended 2026-09-30 | 2026-11-17 16:30 | - | -0.040 | - | - | 12.65 | EPS - · sales - | vs 2025Q3, year-ago quarter · EPS - · sales - | 1 | - |
| 2026Q2ended 2026-06-30 | 2026-08-18 16:30 | -0.070 | -0.010 | -0.070 | 12.57 | 13.59 | EPS +600.0% · sales -7.5% | vs 2025Q2, year-ago quarter · EPS +16.7% · sales -7.4% | 1 | Open -12.16% vs SPY +0.38%. Close -15.83% vs SPY +0.21% |
| 2026Q1ended 2026-03-31 | 2026-05-19 16:30 | -0.030 | -0.070 | -0.030 | 11.80 | 11.91 | EPS -57.1% · sales -0.9% | vs 2025Q1, year-ago quarter · EPS -70.0% · sales -0.8% | 1 | Open -1.90% vs SPY +0.27%. Close -4.76% vs SPY +1.02% |
| 2025Q4ended 2025-12-31 | 2026-03-26 16:30 | -0.010 | -0.020 | -0.011 | 14.72 | 14.74 | EPS -50.0% · sales -0.1% | vs 2024Q4, year-ago quarter · EPS -80.0% · sales +16.0% | 1 | Open -9.63% vs SPY -0.40%. Close -26.67% vs SPY -1.71% |
| 2025Q3ended 2025-09-30 | 2025-11-11 16:30 | -0.090 | - | -0.093 | 12.48 | - | EPS - · sales - | vs 2024Q3, year-ago quarter · EPS -25.0% · sales +7.8% | - | Open -12.61% vs SPY +0.26%. Close -19.82% vs SPY +0.06% |
| 2025Q2ended 2025-06-30 | 2025-08-12 16:30 | -0.060 | - | -0.059 | 13.57 | - | EPS - · sales - | vs 2024Q2, year-ago quarter · EPS -62.5% · sales +7.4% | - | Open +1.54% vs SPY +0.35%. Close -9.23% vs SPY +0.34% |
| 2025Q1ended 2025-03-31 | 2025-05-13 16:30 | -0.100 | - | -0.101 | 11.90 | - | EPS - · sales - | vs 2024Q1, year-ago quarter · EPS -52.4% · sales +1.1% | - | Open 0.00% vs SPY +0.17%. Close -9.09% vs SPY +0.13% |
| 2024Q4ended 2024-12-31 | 2025-03-27 16:30 | -0.050 | - | -0.050 | 12.70 | - | EPS - · sales - | vs 2023Q4, year-ago quarter · EPS -72.2% · sales +1.9% | - | Open +20.05% vs SPY -0.27%. Close +13.15% vs SPY -2.01% |
| 2024Q3ended 2024-09-30 | 2024-11-12 16:30 | -0.120 | - | -0.117 | 11.58 | - | EPS - · sales - | vs 2023Q3, year-ago quarter · EPS +9.1% · sales -9.9% | - | Open +9.93% vs SPY +0.08%. Close +34.04% vs SPY +0.05% |
| 2024Q2ended 2024-06-30 | 2024-08-08 16:30 | -0.160 | -0.120 | -0.165 | 12.63 | 12.80 | EPS +33.3% · sales -1.3% | vs 2023Q2, year-ago quarter · EPS -5.9% · sales -1.7% | 1 | Open +0.53% vs SPY -0.16%. Close -0.53% vs SPY +0.44% |
| 2024Q1ended 2024-03-31 | 2024-05-14 16:30 | -0.210 | -0.120 | -0.213 | 11.76 | 12.00 | EPS +75.0% · sales -2.0% | vs 2023Q1, year-ago quarter · EPS +61.5% · sales -14.2% | 1 | Open -17.53% vs SPY +0.48%. Close -13.96% vs SPY +1.24% |
| 2023Q4ended 2023-12-31 | 2024-03-26 16:30 | -0.180 | -0.050 | -0.182 | 12.46 | 14.90 | EPS +260.0% · sales -16.4% | vs 2022Q4, year-ago quarter · EPS +157.1% · sales -18.0% | 1 | Open +7.57% vs SPY +0.56%. Close +17.53% vs SPY +0.84% |
| 2023Q3ended 2023-09-30 | 2023-11-14 16:30 | -0.110 | -0.125 | -0.108 | 12.85 | 13.48 | EPS -12.0% · sales -4.7% | vs 2022Q3, year-ago quarter · EPS 0.0% · sales -12.2% | 2 | - |
| 2023Q2ended 2023-06-30 | 2023-08-10 16:30 | -0.170 | -0.110 | -0.173 | 12.86 | 14.23 | EPS +54.5% · sales -9.7% | vs 2022Q2, year-ago quarter · EPS +21.4% · sales -6.5% | 2 | - |
| 2023Q1ended 2023-03-31 | 2023-05-11 16:30 | -0.130 | -0.120 | -0.131 | 13.71 | 13.64 | EPS +8.3% · sales +0.5% | vs 2022Q1, year-ago quarter · EPS -13.3% · sales +2.4% | 2 | - |
| 2022Q4ended 2022-12-31 | 2023-03-09 16:30 | -0.070 | -0.110 | -0.072 | 15.20 | 15.16 | EPS -36.4% · sales +0.2% | vs 2021Q4, year-ago quarter · EPS -53.3% · sales -0.4% | 2 | - |
Annual earnings
2025FY EPS -0.260 beat -0.270, from -0.540 a year earlier. Sales 52.68 missed 52.69, from 48.67 a year earlier
Reported years only. The outline behind the bar is the estimate. A later year with no print stays in the table.
earnings feed, not the snapshot. Not the statement ratio.
| Period | EPS adjusted | EPS est | EPS reported | Sales act, USD m | Sales est, USD m | P/E, earnings feed |
|---|---|---|---|---|---|---|
| 2028FYestimate | - | 0.070 | - | - | 60.01 | 10.14 |
| 2027FYestimate | - | 0.000 | - | - | 55.98 | - |
| 2026FYestimate | - | -0.120 | - | - | 52.52 | - |
| 2025FY | -0.260 | -0.270 | -0.260 | 52.68 | 52.69 | - |
| 2024FY | -0.540 | - | -0.542 | 48.67 | - | - |
| 2023FY | -0.590 | -0.460 | -0.593 | 51.87 | 54.30 | - |
| 2022FY | -0.470 | -0.515 | -0.474 | 56.97 | 56.95 | - |
| 2021FY | -0.340 | -0.295 | -0.339 | 53.90 | 53.31 | - |
| 2020FY | -0.460 | -0.550 | -0.457 | 36.35 | 36.28 | - |
| 2019FY | -0.640 | -0.685 | -0.643 | 43.45 | 42.57 | - |
| 2018FY | -1.050 | -1.085 | -1.050 | 42.60 | 42.00 | - |
| 2017FY | -1.110 | -0.930 | -1.110 | 41.59 | 41.57 | - |
| 2016FY | -1.150 | -0.090 | -1.150 | 46.16 | 46.15 | - |
| 2015FY | 0.050 | 0.050 | 0.050 | 41.76 | 41.64 | 14.19 |
| 2014FY | 0.970 | - | 0.970 | 42.81 | - | 0.73 |
| 2013FY | 0.220 | 0.170 | 0.220 | 38.27 | - | 3.23 |
| 2012FY | -0.020 | -0.030 | 0.160 | 33.86 | - | - |
| 2011FY | 0.210 | 0.360 | 0.260 | 33.16 | - | 3.38 |
Quarterly results
2026Q2 revenue 12.57, from 13.57 a year earlier. Operating margin -8.2%, from -6.9% a year earlier
From the quarterly statement. Not an estimate.
Estimate revisions
Latest snapshot of each period and type. 2026FY E -0.12 per share.
| Period | Type | Scale | Date | Mean | vs prior date |
|---|---|---|---|---|---|
| 2026FY | E | per share | 2026-11-02 | -0.12 | 0.0% |
| 2026Q3 | E | per share | 2026-11-02 | -0.04 | 0.0% |
| 2026Q3 | S | per share | 2026-11-02 | 12.65 | 0.0% |
| 2026FY | S | per share | 2026-08-19 | 52.52 | -0.9% |
| 2026Q2 | E | per share | 2026-08-03 | -0.01 | 0.0% |
| 2026Q2 | S | per share | 2026-08-03 | 13.59 | 0.0% |
| 2026Q1 | E | per share | 2026-03-27 | -0.07 | +40.0% |
| 2026Q1 | S | per share | 2026-03-27 | 11.91 | -9.5% |
| 2025FY | E | per share | 2026-02-03 | -0.27 | 0.0% |
| 2025Q4 | E | per share | 2026-02-03 | -0.02 | - |
| 2025FY | S | per share | 2026-02-03 | 52.69 | +1.3% |
| 2025Q4 | S | per share | 2026-02-03 | 14.74 | - |
| 2025Q3 | E | per share | 2024-10-10 | -0.06 | 0.0% |
| 2025Q3 | S | per share | 2024-10-10 | 13.10 | 0.0% |
| 2025Q2 | E | per share | 2024-08-12 | -0.09 | 0.0% |
| 2025Q2 | S | per share | 2024-08-12 | 13.10 | 0.0% |
| 2024FY | E | per share | 2024-08-09 | -0.52 | +6.1% |
| 2024Q3 | E | per share | 2024-08-09 | -0.09 | -10.0% |
| 2024Q4 | E | per share | 2024-08-09 | -0.05 | -16.7% |
| 2025Q1 | E | per share | 2024-08-09 | -0.10 | 0.0% |
| 2024FY | S | per share | 2024-08-09 | 49.60 | -1.6% |
| 2024Q3 | S | per share | 2024-08-09 | 12.50 | -0.8% |
| 2024Q4 | S | per share | 2024-08-09 | 12.80 | -3.0% |
| 2025Q1 | S | per share | 2024-08-09 | 12.10 | -0.8% |
| 2024Q2 | E | per share | 2024-07-29 | -0.12 | 0.0% |
| 2024Q2 | S | per share | 2024-05-15 | 12.80 | -0.8% |
| 2024Q1 | E | per share | 2024-03-27 | -0.12 | +50.0% |
| 2024Q1 | S | per share | 2024-03-27 | 12.00 | -9.1% |
| 2023FY | S | per share | 2024-01-29 | 54.30 | 0.0% |
| 2023FY | E | per share | 2023-12-19 | -0.46 | -8.0% |
Estimate history
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | MRQ |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS per share | -1.11 | -1.05 | -0.643 | -0.457 | -0.339 | -0.474 | -0.593 | -0.542 | -0.262 | -0.2061 | - |
| Sales USD millions | 42 | 43 | 43 | 36 | 54 | 57 | 52 | 49 | 53 | 52 | - |
| Shares million shares | 12 | 14 | 14 | 14 | 16 | 16 | 16 | 17 | 17 | - | 17 |
| Metric | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 |
|---|---|---|---|---|---|---|---|---|---|
| EPS per share | -0.165 | -0.117 | -0.05 | -0.101 | -0.059 | -0.093 | -0.011 | -0.03 | -0.073 |
| Sales USD millions | 13 | 12 | 13 | 12 | 14 | 12 | 15 | 12 | 13 |
| Shares million shares | 16 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 |
Income statement, annual
| Metric | TTM | 2025FY12/31/2025 | 2024FY12/31/2024 | 2023FY12/31/2023 | 2022FY12/31/2022 | 2021FY12/31/2021 | 2020FY12/31/2020 | 2019FY12/31/2019 | 2018FY12/31/2018 |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 51.57 | 52.67+8.2% | 48.67-6.2% | 51.87-9.0% | 56.97+5.7% | 53.90+48.3% | 36.35-16.3% | 43.45+2.0% | 42.60 |
| Cost of Goods Sold Incl. D&A | 33.37 | 33.77+14.5% | 29.50-2.9% | 30.39-4.5% | 31.83+1.9% | 31.23+50.1% | 20.80-18.5% | 25.52+1.5% | 25.14 |
| Gross Profit | 18.21 | 18.90-1.4% | 19.17-10.7% | 21.47-14.6% | 25.14+10.9% | 22.67+45.9% | 15.54-13.3% | 17.92+2.7% | 17.45 |
| Selling, General and Administrative Excl. Other | 20.99 | 21.48-21.8% | 27.47-12.7% | 31.48-3.7% | 32.68+8.2% | 30.20+36.5% | 22.12-17.8% | 26.90-11.3% | 30.32 |
| Research and Development | 3.76 | 3.40-34.4% | 5.18-21.0% | 6.56-6.4% | 7.01+3.7% | 6.76+106.1% | 3.28-10.9% | 3.68-8.2% | 4.01 |
| Other Operating Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -2.78 | -2.57 | -8.30 | -10.01 | -7.54 | -7.53 | -6.58 | -8.97 | -12.87 |
| Interest Expense | - | - | - | 0.00 | 0.00 | - | - | 0.00 | 0.00 |
| Unusual Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -2.50 | 0.00-100.0% | 0.05-66.7% | 0.15 |
| Net Income Before Taxes | -3.40 | -4.38 | -8.84 | -9.48 | -7.48 | -5.18 | -6.30 | -8.77 | -12.78 |
| Income Taxes | 0.15 | 0.06-14.3% | 0.07-22.2% | 0.09+28.6% | 0.07+75.0% | 0.04+33.3% | 0.03-40.0% | 0.05+25.0% | 0.04 |
| Consolidated Net Income | -3.55 | -4.44 | -8.91 | -9.57 | -7.55 | -5.22 | -6.33 | -8.81 | -12.81 |
| Net Income From Continuing Operations | -3.55 | -4.44 | -8.91 | -9.57 | -7.55 | -5.22 | -6.33 | -8.81 | -12.81 |
| Net Income | -3.55 | -4.44 | -8.91 | -9.57 | -7.55 | -5.22 | -6.33 | -8.81 | -12.81 |
| EPS (Recurring) per share | -0.20 | -0.26 | -0.54 | -0.59 | -0.47 | -0.45 | -0.46 | -0.64 | -1.04 |
| EPS (Basic, Before Extraordinaries) per share | -0.21 | -0.26 | -0.54 | -0.59 | -0.47 | -0.34 | -0.46 | -0.64 | -1.05 |
| EPS (Diluted) per share | -0.21 | -0.26 | -0.54 | -0.59 | -0.47 | -0.34 | -0.46 | -0.64 | -1.05 |
| EBITDA | -1.26 | -1.02 | -6.88 | -7.97 | -6.16 | -6.73 | -6.08 | -8.29 | -12.06 |
| Non-Operating Income (Expense) | -0.62 | -1.81 | -0.54-201.9% | 0.53+783.3% | 0.06 | -0.15-153.6% | 0.28+7.7% | 0.26+8.3% | 0.24 |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Option Compensation Expense | 0.58 | 0.61-37.8% | 0.98-24.6% | 1.30+1.6% | 1.28+7.6% | 1.19+45.1% | 0.82-33.9% | 1.24-12.7% | 1.42 |
| Price To Sales Ratio ratio | 0.38 | 0.38 | 0.56 | 0.87 | 0.56 | 1.75 | 0.96 | 0.74 | 1.27 |
| Gross Margin % | 35.31 | 35.89 | 39.39 | 41.40 | 44.13 | 42.05 | 42.76 | 41.25 | 40.97 |
| Operating Margin % | -5.39 | -4.88 | -17.06 | -19.29 | -13.24 | -13.98 | -18.11 | -20.66 | -30.21 |
| Net Margin % | -6.88 | -8.42 | -18.31 | -18.45 | -13.25 | -9.69 | -17.41 | -20.28 | -30.08 |
| Shares Outstanding million shares | 17.45 | 17.31+4.0% | 16.64+2.4% | 16.25+1.6% | 15.99+0.7% | 15.88+14.2% | 13.90+0.8% | 13.79+1.4% | 13.60 |
| Market Capitalization | 12.46 | 12.46-55.4% | 27.95-38.8% | 45.66+42.1% | 32.14-66.8% | 96.94+177.9% | 34.88+13.5% | 30.73-51.9% | 63.89 |
Income statement, quarterly
| Metric | 2026Q26/30/2026 | 2026Q13/31/2026 | 2025Q412/31/2025 | 2025Q39/30/2025 | 2025Q26/30/2025 | 2025Q13/31/2025 | 2024Q412/31/2024 | 2024Q39/30/2024 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 12.57-7.4% | 11.80-0.8% | 14.72+15.9% | 12.48+7.8% | 13.57+7.4% | 11.90+1.2% | 12.70+1.9% | 11.58-9.9% |
| Cost of Goods Sold Incl. D&A | 8.35-6.9% | 7.14+4.4% | 9.33+30.7% | 8.55+15.7% | 8.97+18.3% | 6.84-7.4% | 7.14-6.8% | 7.39+1.1% |
| Gross Profit | 4.22-8.3% | 4.66-7.7% | 5.40-2.7% | 3.93-6.2% | 4.60-8.9% | 5.05+15.6% | 5.55+15.6% | 4.19-24.4% |
| Selling, General and Administrative Excl. Other | 5.25-5.2% | 4.99-5.1% | 5.41-10.6% | 5.34-11.9% | 5.54-28.0% | 5.26-31.4% | 6.05-23.2% | 6.06-16.1% |
| Research and Development | 0.94+8.0% | 0.91+3.4% | 0.95-14.4% | 0.97-25.4% | 0.87-42.0% | 0.88-42.9% | 1.11-34.3% | 1.30-15.6% |
| Other Operating Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -1.03 | -0.32 | -0.01 | -1.41 | -0.94 | -0.20 | -0.50 | -1.87 |
| Unusual Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Before Taxes | -1.20 | -0.47 | -0.16 | -1.57 | -0.97 | -1.67 | -0.84 | -1.92 |
| Income Taxes | 0.07+250.0% | 0.06+500.0% | 0.02 | 0.00-100.0% | 0.020.0% | 0.01-75.0% | -0.01-116.7% | 0.02+100.0% |
| Consolidated Net Income | -1.27 | -0.52 | -0.18 | -1.57 | -0.99 | -1.69 | -0.83 | -1.93 |
| Net Income From Continuing Operations | -1.27 | -0.52 | -0.18 | -1.57 | -0.99 | -1.69 | -0.83 | -1.93 |
| Net Income | -1.27 | -0.52 | -0.18 | -1.57 | -0.99 | -1.69 | -0.83 | -1.93 |
| EPS (Recurring) per share | -0.07 | -0.03 | -0.01 | -0.09 | -0.06 | -0.10 | -0.05 | -0.12 |
| EPS (Basic, Before Extraordinaries) per share | -0.07 | -0.03 | -0.01 | -0.09 | -0.06 | -0.10 | -0.05 | -0.12 |
| EPS (Diluted) per share | -0.07 | -0.03 | -0.01 | -0.09 | -0.06 | -0.10 | -0.05 | -0.12 |
| EBITDA | -0.67 | 0.05-72.2% | 0.41 | -1.04 | -0.56 | 0.18 | -0.12 | -1.59 |
| Non-Operating Income (Expense) | -0.17 | -0.14 | -0.15 | -0.16 | -0.03 | -1.47 | -0.34-288.9% | -0.05 |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Option Compensation Expense | 0.17-15.0% | 0.170.0% | 0.17-32.0% | 0.07-22.2% | 0.20-39.4% | 0.17-45.2% | 0.25-21.9% | 0.09-69.0% |
| Price To Sales Ratio ratio | 0.38 | 0.32 | 0.38 | 0.39 | 0.30 | 0.34 | 0.57 | 0.61 |
| Gross Margin % | 33.56 | 39.50 | 36.65 | 31.50 | 33.92 | 42.49 | 43.74 | 36.18 |
| Operating Margin % | -8.19 | -2.75 | -0.10 | -11.30 | -6.93 | -1.72 | -3.95 | -16.15 |
| Net Margin % | -10.07 | -4.44 | -1.25 | -12.60 | -7.32 | -14.17 | -6.57 | -16.69 |
| Shares Outstanding million shares | 17.45+3.8% | 17.40+3.6% | 17.31+4.0% | 17.05+2.5% | 16.81+2.2% | 16.79+3.3% | 16.64+2.4% | 16.64+2.5% |
| Market Capitalization | 12.46-15.9% | 17.36+5.4% | 19.60-29.9% | 19.38-33.4% | 14.81-57.8% | 16.47-66.0% | 27.95-38.8% | 29.11-29.4% |
Balance sheet, annual
| Metric | 2025FY12/31/2025 | 2024FY12/31/2024 | 2023FY12/31/2023 | 2022FY12/31/2022 | 2021FY12/31/2021 | 2020FY12/31/2020 | 2019FY12/31/2019 | 2018FY12/31/2018 | 2017FY12/31/2017 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 6.03+152.3% | 2.39-66.0% | 7.03-49.5% | 13.92-41.6% | 23.85+105.1% | 11.63-8.1% | 12.65-40.3% | 21.19-2.4% | 21.71 |
| Short Term Receivables | 9.54+13.7% | 8.39-13.1% | 9.65-1.2% | 9.77+0.5% | 9.72+33.3% | 7.29-21.8% | 9.32+2.6% | 9.08+15.5% | 7.86 |
| Inventories | 7.88-27.2% | 10.82+9.2% | 9.91-6.6% | 10.61+39.4% | 7.61+33.3% | 5.71-30.1% | 8.17-7.1% | 8.79-6.3% | 9.38 |
| Other Current Assets | 1.80-8.2% | 1.96+127.9% | 0.86-41.5% | 1.47+37.4% | 1.07+46.6% | 0.73+82.5% | 0.40-27.3% | 0.55+10.0% | 0.50 |
| Total Current Assets | 25.25+7.2% | 23.56-14.2% | 27.45-23.3% | 35.77-15.3% | 42.25+66.6% | 25.36-17.0% | 30.55-22.9% | 39.62+0.4% | 39.45 |
| Net Property, Plant & Equipment | 0.83-56.5% | 1.91-35.9% | 2.98+39.9% | 2.13-28.8% | 2.99+59.0% | 1.88-46.1% | 3.49+186.1% | 1.22-12.9% | 1.40 |
| Total Investments and Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Intangible Assets | 1.95-14.1% | 2.27-13.0% | 2.61-11.2% | 2.94-7.3% | 3.17+428.3% | 0.60-3.2% | 0.62-1.6% | 0.63-3.1% | 0.65 |
| Other Assets | 1.12-19.4% | 1.39-0.7% | 1.40-4.1% | 1.46+440.7% | 0.27+107.7% | 0.13-13.3% | 0.15-25.0% | 0.20+42.9% | 0.14 |
| Total Assets | 29.15+0.0% | 29.14-15.4% | 34.44-18.6% | 42.29-13.1% | 48.69+74.1% | 27.97-19.6% | 34.81-16.5% | 41.67+0.0% | 41.65 |
| Short Term Debt Incl. Current Port. of LT Debt | 0.70-75.3% | 2.83+185.9% | 0.99-4.8% | 1.04+11.8% | 0.93-65.0% | 2.66+88.7% | 1.41 | 0.00 | 0.00 |
| Accounts Payable | 5.38-23.0% | 6.99+55.3% | 4.50+16.6% | 3.86+39.4% | 2.77+140.9% | 1.15-55.6% | 2.59+2.8% | 2.52+46.5% | 1.72 |
| Income Tax Payable | 0.03-80.0% | 0.15+50.0% | 0.10+42.9% | 0.070.0% | 0.07 | - | - | 0.03-50.0% | 0.06 |
| Other Current Liabilities | 7.09+7.4% | 6.60-10.6% | 7.38-1.5% | 7.49-15.6% | 8.87+81.8% | 4.88-15.4% | 5.77-32.5% | 8.55-0.7% | 8.61 |
| Total Current Liabilities | 13.21-20.2% | 16.56+27.7% | 12.97+4.2% | 12.45-1.6% | 12.65+45.7% | 8.68-11.2% | 9.78-11.8% | 11.09+6.7% | 10.39 |
| Long Term Debt | 3.83+111.6% | 1.81+3.4% | 1.75+139.7% | 0.73-57.8% | 1.73+13.1% | 1.53-14.5% | 1.79 | 0.00 | 0.00 |
| Provision for Risks Charges | 0.00 | 0.00-100.0% | 0.14+27.3% | 0.11+83.3% | 0.06-25.0% | 0.08-50.0% | 0.16-33.3% | 0.24+20.0% | 0.20 |
| Other Liabilities | 7.19-17.0% | 8.66-13.8% | 10.05-14.6% | 11.77+7.4% | 10.96+3435.5% | 0.31-18.4% | 0.38-2.6% | 0.39-26.4% | 0.53 |
| Total Liabilities | 24.23-10.4% | 27.04+8.6% | 24.91-0.6% | 25.06-1.3% | 25.39+139.5% | 10.60-12.5% | 12.11+3.4% | 11.71+5.3% | 11.12 |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 6.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Equity | -1.08-151.4% | 2.10-77.9% | 9.52-44.7% | 17.23-26.1% | 23.30+34.1% | 17.37-23.5% | 22.70-24.2% | 29.96-1.8% | 30.52 |
| Total Shareholders Equity | 4.92+134.3% | 2.10-77.9% | 9.52-44.7% | 17.23-26.1% | 23.30+34.1% | 17.37-23.5% | 22.70-24.2% | 29.96-1.8% | 30.52 |
| Accumulated Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Equity | 4.92+134.3% | 2.10-77.9% | 9.52-44.7% | 17.23-26.1% | 23.30+34.1% | 17.37-23.5% | 22.70-24.2% | 29.96-1.8% | 30.52 |
| Total Liabilities & Stockholders Equity | 29.15+0.0% | 29.14-15.4% | 34.44-18.6% | 42.29-13.1% | 48.69+74.1% | 27.97-19.6% | 34.81-16.5% | 41.67+0.0% | 41.65 |
| Book Value Per Share per share | -0.06-146.2% | 0.13-78.0% | 0.59-45.4% | 1.08-26.5% | 1.47+17.6% | 1.25-24.2% | 1.65-25.0% | 2.20-16.3% | 2.63 |
| Tangible Book Value Per Share per share | -0.17 | -0.01-102.3% | 0.43-51.7% | 0.89-29.9% | 1.27+5.0% | 1.21-24.4% | 1.60-25.9% | 2.16-16.3% | 2.58 |
| Full-Time Employees people | 930.0% | 93-16.2% | 111-14.6% | 130+9.2% | 119+33.7% | 89-5.3% | 94-17.5% | 114-1.7% | 116 |
| Price to Book Ratio ratio | -5.24 | 10.66 | 3.78 | 1.78 | 4.16 | 2.01 | 1.35 | 2.13 | 2.51 |
| Return on Assets % | -15.22 | -28.03 | -24.95 | -16.59 | -13.63 | -20.16 | -23.05 | -30.76 | -28.66 |
| Return on Equity % | -126.43 | -153.37 | -71.54 | -37.24 | -25.70 | -31.59 | -33.47 | -42.37 | -36.93 |
| Return on Invested Capital % | -50.68 | -227.76 | -84.89 | -42.01 | -20.88 | -33.49 | -35.97 | -42.77 | -42.16 |
| Quick Ratio ratio | 1.32 | 0.77 | 1.35 | 2.02 | 2.74 | 2.26 | 2.29 | 2.78 | 2.89 |
| Current Ratio ratio | 1.91 | 1.42 | 2.12 | 2.87 | 3.34 | 2.92 | 3.12 | 3.57 | 3.80 |
Cash flow, annual
| Metric | TTM | 2025FY12/31/2025 | 2024FY12/31/2024 | 2023FY12/31/2023 | 2022FY12/31/2022 | 2021FY12/31/2021 | 2020FY12/31/2020 | 2019FY12/31/2019 | 2018FY12/31/2018 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income | -3.55 | -4.44 | -8.91 | -9.57 | -7.55 | -5.22 | -6.33 | -8.81 | -12.81 |
| Depreciation | 1.52 | 1.55+9.2% | 1.42-30.0% | 2.03+47.1% | 1.38+72.5% | 0.80+60.0% | 0.50-27.5% | 0.69-14.8% | 0.81 |
| Other Funds (Non Cash) | 1.67 | 3.16+101.3% | 1.57-4.8% | 1.65-8.8% | 1.81 | -0.83-162.9% | 1.32-25.8% | 1.78-9.2% | 1.96 |
| Funds from Operations | -0.35 | 0.27 | -5.92 | -5.89 | -4.36 | -5.25 | -4.51 | -6.35 | -10.05 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | -1.38 | -2.38 | -1.37 | -0.86 | -5.16-138.3% | 13.47+960.6% | 1.27 | -1.56-7900.0% | 0.02 |
| Cash from Operating Activities | -1.73 | -2.12 | -7.29 | -6.75 | -9.52-215.8% | 8.22 | -3.24 | -7.91 | -10.03 |
| Capital Expenditures | -0.27 | -0.14 | -0.01 | -0.11 | -0.29 | -0.21 | -0.10 | -0.13 | -0.44 |
| Net Assets From Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -5.34 | 0.00 | 0.00 | 0.00 |
| Sale of Fixed Assets and Businesses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - |
| Purchase or Sale of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale Or Maturity of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Uses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.38 | -0.39 |
| Other Sources | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Investing Activities | -0.27 | -0.14 | -0.01 | -0.11 | -0.29 | -5.56 | -0.09 | -0.51 | -0.83 |
| Cash Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | 0.00 | 6.00 | 0.00-100.0% | 0.08+300.0% | 0.02-99.8% | 10.10 | 0.00 | 0.00-100.0% | 10.57 |
| Repurchase of Common Pref Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Common Pref Stock | 0.00 | 6.00 | 0.00-100.0% | 0.08+300.0% | 0.02-99.8% | 10.10 | 0.00 | 0.00-100.0% | 10.57 |
| Proceedsfrom Stock Options | 0.00 | 6.00 | 0.00 | 0.00 | 0.00-100.0% | 9.88 | 0.00 | 0.00-100.0% | 10.47 |
| Issuance or Reduction of Debt, Net | 0.00 | 0.04-98.5% | 2.66 | 0.00 | 0.00 | 0.00-100.0% | 2.50 | 0.00 | 0.00 |
| Change in Long Term Debt | 0.00 | 0.04-98.5% | 2.66 | 0.00 | 0.00 | 0.00-100.0% | 2.50 | 0.00 | 0.00 |
| Issuance of Long Term Debt | 0.00 | 4.00+38.9% | 2.88 | 0.00 | 0.00 | 0.00-100.0% | 2.50 | 0.00 | 0.00 |
| Reduction of Long Term Debt | 0.00 | -3.96 | -0.22 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Financing Active Other Cash Flow | -0.10 | -0.07 | -0.06 | -0.09 | -0.09 | -0.63 | -0.03 | -0.16 | -0.19 |
| Other Financing Activities Uses | -0.10 | -0.07 | -0.06 | -0.09 | -0.09 | -0.63 | -0.03 | -0.16 | -0.19 |
| Cash from Financing Activities | -0.10 | 5.96+129.2% | 2.60 | -0.01 | -0.07-100.7% | 9.47+283.4% | 2.47 | -0.16-101.5% | 10.38 |
| Exchange Rate Effect | 0.00 | -0.07-240.0% | 0.05 | -0.03 | -0.05-150.0% | 0.10 | -0.16-500.0% | 0.04 | -0.04 |
| Net Change in Cash | -2.10 | 3.64 | -4.65 | -6.89 | -9.93-181.2% | 12.23 | -1.03 | -8.54 | -0.51 |
| Free Cash Flow | -2.00 | -2.26 | -7.30 | -6.85 | -9.80-222.5% | 8.00 | -3.33 | -8.04 | -10.46 |
| Preferred Dividends (Cash Flow) | - | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price to Free Cash Flow ratio | - | - | - | - | - | 11.77 | - | - | - |
| Deferred Taxes & Investment Tax Credit | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Balance sheet, quarterly
| Metric | 2026Q26/30/2026 | 2026Q13/31/2026 | 2025Q412/31/2025 | 2025Q39/30/2025 | 2025Q26/30/2025 | 2025Q13/31/2025 | 2024Q412/31/2024 | 2024Q39/30/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 4.68-31.0% | 4.59-36.6% | 6.03+152.3% | 5.57+44.3% | 6.78+65.0% | 7.24+33.6% | 2.39-66.0% | 3.86-51.6% |
| Short Term Receivables | 7.09-29.3% | 8.42-10.3% | 9.54+13.7% | 9.53+22.5% | 10.03+24.8% | 9.39+2.6% | 8.39-13.1% | 7.78-4.1% |
| Inventories | 9.75+15.5% | 9.32-8.1% | 7.88-27.2% | 7.30-33.3% | 8.44-24.1% | 10.14-7.8% | 10.82+9.2% | 10.94+8.1% |
| Other Current Assets | 2.44+50.6% | 2.25-4.7% | 1.80-8.2% | 1.66-5.1% | 1.62-6.4% | 2.36+17.4% | 1.96+127.9% | 1.75+54.9% |
| Total Current Assets | 23.96-10.8% | 24.58-15.6% | 25.25+7.2% | 24.07-1.1% | 26.87+7.4% | 29.13+5.6% | 23.56-14.2% | 24.34-11.0% |
| Net Property, Plant & Equipment | 0.40-69.9% | 0.64-60.5% | 0.83-56.5% | 1.06-51.6% | 1.33-44.1% | 1.62-39.3% | 1.91-35.9% | 2.19-33.8% |
| Total Investments and Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Intangible Assets | 1.79-15.2% | 1.87-14.6% | 1.95-14.1% | 2.03-14.0% | 2.11-13.5% | 2.19-13.1% | 2.27-13.0% | 2.36-12.3% |
| Other Assets | 1.11-12.6% | 1.19-8.5% | 1.12-19.4% | 1.20-5.5% | 1.27-10.6% | 1.30-1.5% | 1.39-0.7% | 1.27-20.6% |
| Total Assets | 27.26-13.7% | 28.27-17.4% | 29.15+0.0% | 28.35-6.0% | 31.59+1.1% | 34.24+0.4% | 29.14-15.4% | 30.15-13.7% |
| Short Term Debt Incl. Current Port. of LT Debt | 0.14-87.8% | 0.42-62.5% | 0.70-75.3% | 1.03-55.4% | 1.15+16.2% | 1.12+13.1% | 2.83+185.9% | 2.31+133.3% |
| Accounts Payable | 6.65+25.2% | 5.75-5.0% | 5.38-23.0% | 4.41-28.9% | 5.31-31.7% | 6.05-21.2% | 6.99+55.3% | 6.20+137.5% |
| Income Tax Payable | - | - | 0.03-80.0% | - | - | - | 0.15+50.0% | - |
| Other Current Liabilities | 6.38-12.0% | 6.65-14.5% | 7.09+7.4% | 6.96-5.2% | 7.25-1.8% | 7.78+5.3% | 6.60-10.6% | 7.34+8.9% |
| Total Current Liabilities | 13.17-3.9% | 12.83-14.2% | 13.21-20.2% | 12.39-21.8% | 13.71-15.1% | 14.95-7.0% | 16.56+27.7% | 15.85+53.1% |
| Long Term Debt | 3.87-1.3% | 3.85-62.2% | 3.83+111.6% | 3.76+44.6% | 3.92+203.9% | 10.18+565.4% | 1.81+3.4% | 2.60+36.8% |
| Provision for Risks Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 0.00-100.0% |
| Other Liabilities | 6.57-16.7% | 6.86-16.9% | 7.19-17.0% | 7.52-17.2% | 7.89-17.5% | 8.26-17.5% | 8.66-13.8% | 9.08-13.5% |
| Total Liabilities | 23.62-7.5% | 23.54-29.5% | 24.23-10.4% | 23.67-14.0% | 25.53-5.4% | 33.38+20.9% | 27.04+8.6% | 27.53+20.3% |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 6.000.0% | 6.00 | 6.00 | 6.00 | 6.00 | 0.00 | 0.00 | 0.00 |
| Common Equity | -2.36-4033.3% | -1.27-249.4% | -1.08-151.4% | -1.32-150.4% | 0.06-98.6% | 0.85-86.9% | 2.10-77.9% | 2.62-78.3% |
| Total Shareholders Equity | 3.64-39.9% | 4.73+456.5% | 4.92+134.3% | 4.68+78.6% | 6.06+42.6% | 0.85-86.9% | 2.10-77.9% | 2.62-78.3% |
| Accumulated Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Equity | 3.64-39.9% | 4.73+456.5% | 4.92+134.3% | 4.68+78.6% | 6.06+42.6% | 0.85-86.9% | 2.10-77.9% | 2.62-78.3% |
| Total Liabilities & Stockholders Equity | 27.26-13.7% | 28.27-17.4% | 29.15+0.0% | 28.35-6.0% | 31.59+1.1% | 34.24+0.4% | 29.14-15.4% | 30.15-13.7% |
| Book Value Per Share per share | -0.14 | -0.07-240.0% | -0.06-146.2% | -0.08-150.0% | 0.00-100.0% | 0.05-87.5% | 0.13-78.0% | 0.16-78.4% |
| Tangible Book Value Per Share per share | -0.24 | -0.18 | -0.17 | -0.20-1100.0% | -0.12-209.1% | -0.08-133.3% | -0.01-102.3% | 0.02-96.6% |
| Full-Time Employees people | - | - | 930.0% | - | - | - | 93-16.2% | - |
| Price to Book Ratio ratio | -5.24 | -13.06 | -14.74 | 324.93 | 17.38 | 7.85 | 10.66 | 11.10 |
| Return on Assets % | -12.06 | -10.48 | -15.22 | -17.39 | -17.34 | -20.88 | -28.03 | -33.90 |
| Return on Equity % | -73.15 | -117.30 | -126.43 | -139.29 | -105.72 | -194.33 | -153.37 | -150.28 |
| Return on Invested Capital % | -16.86 | -6.10 | -2.10 | -18.64 | -9.96 | -15.28 | -21.32 | -37.02 |
| Quick Ratio ratio | 1.08 | 1.19 | 1.32 | 1.35 | 1.34 | 1.27 | 0.77 | 0.85 |
| Current Ratio ratio | 1.82 | 1.92 | 1.91 | 1.94 | 1.96 | 1.95 | 1.42 | 1.54 |
Cash flow, quarterly
| Metric | 2026Q26/30/2026 | 2026Q13/31/2026 | 2025Q412/31/2025 | 2025Q39/30/2025 | 2025Q26/30/2025 | 2025Q13/31/2025 | 2024Q412/31/2024 | 2024Q39/30/2024 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -1.27 | -0.52 | -0.18 | -1.57 | -0.99 | -1.69 | -0.83 | -1.93 |
| Depreciation | 0.36-5.3% | 0.37-2.6% | 0.42+10.5% | 0.37+32.1% | 0.38+2.7% | 0.38-5.0% | 0.38-51.3% | 0.28-20.0% |
| Other Funds (Non Cash) | 0.24-17.2% | 0.24-85.7% | 0.24-52.9% | 0.94+291.7% | 0.29-31.0% | 1.68+330.8% | 0.51+24.4% | 0.24-35.1% |
| Funds from Operations | -0.66 | 0.09-76.3% | 0.48+700.0% | -0.26 | -0.33 | 0.38 | 0.06 | -1.41 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | 0.84 | -1.42 | 0.11 | -0.90 | -0.07-112.5% | -1.53-250.0% | -1.29-261.3% | -1.66 |
| Cash from Operating Activities | 0.17 | -1.33 | 0.59 | -1.16 | -0.40 | -1.15 | -1.24 | -3.07 |
| Capital Expenditures | -0.05 | -0.10 | -0.11 | -0.01 | -0.01 | -0.01 | -0.01-133.3% | -0.00 |
| Net Assets From Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Fixed Assets and Businesses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase or Sale of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale Or Maturity of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Uses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Sources | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Investing Activities | -0.05 | -0.10 | -0.11 | -0.01 | -0.01 | -0.01 | -0.01-133.3% | -0.00 |
| Cash Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Dividends (Cash Flow) | - | - | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | 0.00 | 0.00-100.0% | 0.00 | 0.00 | 0.00 | 6.00 | 0.00-100.0% | 0.00 |
| Repurchase of Common Pref Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Common Pref Stock | 0.00 | 0.00-100.0% | 0.00 | 0.00 | 0.00 | 6.00 | 0.00-100.0% | 0.00 |
| Proceedsfrom Stock Options | 0.00 | 0.00-100.0% | 0.00 | 0.00 | 0.00 | 6.00 | 0.00 | 0.00 |
| Issuance or Reduction of Debt, Net | 0.00 | 0.00-100.0% | 0.00 | 0.00-100.0% | 0.00 | 0.04 | -0.22 | 2.88 |
| Change in Long Term Debt | 0.00 | 0.00-100.0% | 0.00 | 0.00-100.0% | 0.00 | 0.04 | -0.22 | 2.88 |
| Issuance of Long Term Debt | 0.00 | 0.00-100.0% | 0.00 | 0.00-100.0% | 0.00 | 4.00 | 0.00 | 2.88 |
| Reduction of Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -3.96 | -0.22 | 0.00 |
| Net Financing Active Other Cash Flow | -0.04 | -0.00 | -0.03 | -0.03 | -0.01 | 0.00 | 0.00 | -0.06 |
| Other Financing Activities Uses | -0.04 | -0.00 | -0.03 | -0.03 | -0.01 | 0.00 | 0.00 | -0.06 |
| Cash from Financing Activities | -0.04 | -0.00-100.0% | -0.03 | -0.03-101.1% | -0.01 | 6.04 | -0.22-650.0% | 2.82 |
| Exchange Rate Effect | -0.00 | 0.00 | -0.00 | 0.00 | -0.04-300.0% | -0.02-150.0% | -0.01 | 0.00-100.0% |
| Net Change in Cash | 0.09 | -1.43-129.4% | 0.46 | -1.21 | -0.47 | 4.86 | -1.47 | -0.25 |
| Free Cash Flow | 0.12 | -1.44 | 0.48 | -1.17 | -0.41 | -1.16 | -1.25 | -3.07 |
Revenue breakdown
USD millions, so a column adds up to the income statement. Share is of the latest year in that split. The change is versus the older year shown, not TTM.
| Name | 2024 | 2025 | vs 2024 | 2025 share |
|---|---|---|---|---|
| Cyclo G Six | 12.70 | 13.84 | +9.0% | 26.3% |
| Product and Service, Other | 8.15 | 8.55 | +5.0% | 16.2% |
| Retina | 27.83 | 30.28 | +8.8% | 57.5% |
| Total | 48.67 | 52.68 | +8.2% | 100.0% |
| Name | 2024 | 2025 | vs 2024 | 2025 share |
|---|---|---|---|---|
| Americas Excluding U S | 2.21 | 2.12 | -3.8% | 4.0% |
| Asia Pacific | 11.95 | 12.95 | +8.4% | 24.6% |
| Europe, Middle East and Africa | 11.82 | 14.39 | +21.7% | 27.3% |
| United States | 22.69 | 23.21 | +2.3% | 44.1% |
| Total | 48.67 | 52.68 | +8.2% | 100.0% |
Short interest
shares short against float, oldest to newest| Settlement | Of float | Shares short | Float | Avg volume |
|---|---|---|---|---|
| 2026-10-30 | 0.37% | 0.0M | 10.7M | 388.39K |
| 2026-10-15 | 0.71% | 0.1M | 10.7M | 394.16K |
| 2026-09-30 | 1.21% | 0.1M | 10.9M | 67.60K |
| 2026-09-15 | 1.48% | 0.2M | 10.9M | 69.48K |
| 2026-08-31 | 1.36% | 0.1M | 10.9M | 71.73K |
| 2026-08-14 | 0.35% | 0.0M | 10.8M | 56.92K |
| 2026-07-31 | 0.27% | 0.0M | 10.7M | 56.40K |
| 2026-07-15 | 0.30% | 0.0M | 11.9M | 57.16K |
| 2026-06-30 | 0.25% | 0.0M | 12.2M | 252.92K |
| 2026-06-15 | 0.18% | 0.0M | 12.2M | 255.74K |
| 2026-05-29 | 0.23% | 0.0M | 12.2M | 250.56K |
| 2026-05-15 | 0.23% | 0.0M | 12.4M | 247.09K |
| 2026-04-30 | 0.48% | 0.1M | 11.7M | 253.59K |
| 2026-04-15 | 0.90% | 0.1M | 11.6M | 271.99K |
| 2026-03-31 | 0.28% | 0.0M | 11.7M | 84.69K |
| 2026-03-13 | 0.41% | 0.0M | 11.7M | 87.21K |
| 2026-02-27 | 0.39% | 0.0M | 11.7M | 92.59K |
| 2026-02-13 | 0.63% | 0.1M | 11.7M | 97.32K |
| 2026-01-30 | 1.18% | 0.1M | 11.7M | 107.55K |
| 2026-01-15 | 2.31% | 0.3M | 11.7M | 88.10K |
Option chain
expiry 2026-11-20| Type | Strike | Bid | Ask | Last | IV | Open int | Volume | Delta | Theta | Vega |
|---|---|---|---|---|---|---|---|---|---|---|
| call | 2.50 | 0.00 | 0.70 | 0.04 | - | 1.00 | 0.00 | 0.992 | -0.005 | 0.000 |
| call | 5.00 | 0.00 | 0.70 | 0.00 | - | 0.00 | 0.00 | 0.992 | -0.005 | 0.000 |
| call | 7.50 | 0.00 | 0.70 | 0.00 | - | 0.00 | 0.00 | 0.992 | -0.006 | 0.000 |
| put | 2.50 | 1.45 | 2.15 | 1.83 | - | 1.00 | 0.00 | -0.008 | -0.005 | 0.000 |
| put | 5.00 | 3.80 | 4.90 | 0.00 | - | 0.00 | 0.00 | -0.008 | -0.005 | 0.000 |
| put | 7.50 | 6.30 | 7.30 | 0.00 | - | 0.00 | 0.00 | -0.008 | -0.005 | 0.000 |
Latest SEC filings
30| Filed | Form | Description | Period | Link |
|---|---|---|---|---|
| 2026-10-13 | 4 | Statement of changes in beneficial ownership of securities | 2026-10-02 | SEC |
| 2026-10-07 | 4 | Statement of changes in beneficial ownership of securities | 2025-03-25 | SEC |
| 2026-10-07 | 4 | Statement of changes in beneficial ownership of securities | 2025-03-25 | SEC |
| 2026-10-07 | 4 | Statement of changes in beneficial ownership of securities | 2025-03-25 | SEC |
| 2026-10-05 | 4 | Statement of changes in beneficial ownership of securities | 2026-10-01 | SEC |
| 2026-09-16 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-16 | SEC |
| 2026-09-14 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-14 | SEC |
| 2026-09-10 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-10 | SEC |
| 2026-09-02 | 8-K | Current report | 2026-08-27 | SEC |
| 2026-08-24 | 4 | Statement of changes in beneficial ownership of securities | 2026-08-24 | SEC |
| 2026-08-18 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 2026-07-04 | SEC |
| 2026-08-18 | 8-K | Current report | 2026-08-18 | SEC |
| 2026-07-16 | 8-K | Current report | 2026-07-10 | SEC |
| 2026-07-14 | 4 | Statement of changes in beneficial ownership of securities | 2026-07-10 | SEC |
| 2026-07-14 | 4 | Statement of changes in beneficial ownership of securities | 2026-07-10 | SEC |
| 2026-07-13 | SCHEDULE 13D/A | SEC | ||
| 2026-07-08 | 4 | Statement of changes in beneficial ownership of securities | 2026-07-07 | SEC |
| 2026-06-18 | 8-K | Current report | 2026-06-12 | SEC |
| 2026-06-16 | 4 | Statement of changes in beneficial ownership of securities | 2026-06-13 | SEC |
| 2026-06-16 | 4 | Statement of changes in beneficial ownership of securities | 2026-06-13 | SEC |
| 2026-06-15 | 4 | Statement of changes in beneficial ownership of securities | 2026-06-12 | SEC |
| 2026-06-12 | 4 | Statement of changes in beneficial ownership of securities | 2026-06-11 | SEC |
| 2026-06-09 | 4 | Statement of changes in beneficial ownership of securities | 2026-06-08 | SEC |
| 2026-06-08 | 4 | Statement of changes in beneficial ownership of securities | 2026-06-05 | SEC |
| 2026-06-03 | 4 | Statement of changes in beneficial ownership of securities | 2026-06-03 | SEC |
| 2026-06-01 | SD | Specialized Disclosure Report | SEC | |
| 2026-05-26 | 4 | Statement of changes in beneficial ownership of securities | 2026-05-26 | SEC |
| 2026-05-26 | 4 | Statement of changes in beneficial ownership of securities | 2026-05-26 | SEC |
| 2026-05-19 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 2026-04-04 | SEC |
| 2026-05-19 | 8-K | Current report | 2026-05-19 | SEC |
Insider activity by month
| Month | Bought | Buys | Sold | Sells |
|---|---|---|---|---|
| 2026-11 | 0 | 0 | 0 | 0 |
| 2026-10 | 0 | 0 | 0 | 0 |
| 2026-09 | 9.98K | 3 | 0 | 0 |
| 2026-08 | 5.00K | 1 | 0 | 0 |
| 2026-07 | 0 | 0 | 0 | 0 |
| 2026-06 | 11.41K | 5 | 0 | 0 |
| 2026-05 | 5.00K | 1 | 0 | 0 |
| 2026-04 | 0 | 0 | 0 | 0 |
| 2026-03 | 74.45K | 9 | 0 | 0 |
| 2026-02 | 140.80K | 11 | 0 | 0 |
| 2026-01 | 154.47K | 13 | 0 | 0 |
| 2025-12 | 134.94K | 14 | 0 | 0 |
| 2025-11 | 124.40K | 15 | 0 | 0 |
Institutional holders
| Manager | % owned |
|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 2.96% |
| RENAISSANCE TECHNOLOGIES LLC | 1.90% |
| MORGAN STANLEY | 1.75% |
| WEBER CAPITAL MANAGEMENT LLC /ADV | 0.84% |
| GEODE CAPITAL MANAGEMENT, LLC | 0.79% |
| CITADEL ADVISORS LLC | 0.57% |
| VANGUARD FIDUCIARY TRUST CO | 0.35% |
| STATE STREET CORP | 0.25% |
| PERKINS CAPITAL MANAGEMENT INC | 0.23% |
| GOLDMAN SACHS GROUP INC | 0.23% |
Funds
| Fund | % owned |
|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND | 2.31% |
| VANGUARD EXTENDED MARKET INDEX FUND | 0.65% |
| Fidelity Extended Market Index Fund | 0.41% |
| Fidelity Series Total Market Index Fund | 0.10% |
| Fidelity Total Market Index Fund | 0.08% |
| Fidelity Nasdaq Composite Index Fund | 0.06% |
OakChart. IRIX. Cached 15 minutes. Terms